RST-SANEXAS is a privately held Nevada C-Corporation that was formed to integrate the laws of physics with advanced electronic engineering. The staff and consultant advisors of RST are made up of several prominent MD’s, DO’s and scientific PhD’s to focus on the pain, circulatory and rehabilitation sector of modern healthcare and to target non-invasive, non-pharmaceutical, quantum physics-based treatment options.
For three decades, our ardent, progressive research team members have been developing, refining, clinically testing, test-marketing and authoring scientific papers with its breakthrough Electric cell-Signaling and quantum-based harmonic resonant frequency technologies.
In 1995, RST-SANEXAS medical devices were revamped to use quantum-based communications-level technology with both frequency modulation (FM), as well as the typical amplitude modulated (AM) electronic signals. To this day, amplitude modulation (AM) signals represent 99% of all marketed TENS type devices even though the human body operates exclusively by (FM) frequency modulated energy.
In 1996, after exhaustive clinical application data was received, a new electronic signal generating patent was issued (UHdfg). The patent covers this brand new advanced random, yet sequential AM/FM signal generation technique with spread spectrum frequency hopping technology (FHSS). RST-SANEXAS technology is still fundamentally more advanced than any other electromedical device in use today and is the number one pain modality available to the healthcare industry.